کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
189493 | 459680 | 2011 | 6 صفحه PDF | دانلود رایگان |

In this work, a multiplex immunoassay was constructed based on the amplification strategy using the liposomes which contained different electrochemical active molecule as singal enhancer for the simultaneous quantify neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP). First of all, the liposomes encapsulated with electrochemical active molecules, ascorbic acid (AA) and uric acid (UA), were prepared as immune labels respectively. With the sandwich type immunoreactions format, the marker entrapped liposomes labeled secondary antibodies were employed to form the immune complex, which were then destroyed by the addition of surfactant and the entrapped marker was electrochemically detected using carbon nanotubes modified electrodes. Based on the new signal amplification strategy, the immunoassay could simultaneous multiplexed detected ProGRP and NSE in the concentration range from 50 to 1000 pg/mL and 5.0 to 100 ng/mL, respectively. In conclusion, the multiplex immunoassay can offer higher sample throughput, less sample consumption, shorter assay time and lower cost than the traditional parallel single-analyte immunoassay.
► A novel principle for simultaneous detection of two cancer biomarkers based on the amplification strategy using the liposomes, which contained different electrchemical active molecules of ascorbic acid (AA) and uric acid (UA) as singal enhancer, was developed based on sandwich-type immunoreaction.
► Based on the new signal amplification strategy, the immunoassay could simultaneous multiplexed detected two kind of tumor biomarkers for small cell lung cancer, neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP), in the concentration range from 50 to 1000 pg/mL and 5.0 to 100 ng/mL, respectively.
Journal: Electrochimica Acta - Volume 56, Issue 16, 30 June 2011, Pages 5624–5629